within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XK02_Niraparib;
model Niraparib 
   extends Pharmacolibrary.Drugs.ATC.L.L01XK02;

  annotation(Documentation(
    info ="<html><body><p>Niraparib is an oral, selective poly(ADP-ribose) polymerase (PARP) inhibitor, primarily used as an anti-cancer agent for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is an approved drug for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data from adult female ovarian cancer patients after oral administration of niraparib.</p><h4>References</h4><ol><li><p>Chryssafidis, P, et al., &amp; Macheras, P (2022). Re-writing Oral Pharmacokinetics Using Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models. <i>Pharmaceutical research</i> 39(4) 691–701. DOI:<a href=&quot;https://doi.org/10.1007/s11095-022-03230-0&quot;>10.1007/s11095-022-03230-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35378697/&quot;>https://pubmed.ncbi.nlm.nih.gov/35378697</a></p></li><li><p>van Andel, L, et al., &amp; Beijnen, JH (2018). Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a . <i>Cancer chemotherapy and pharmacology</i> 81(1) 39–46. DOI:<a href=&quot;https://doi.org/10.1007/s00280-017-3455-x&quot;>10.1007/s00280-017-3455-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29043410/&quot;>https://pubmed.ncbi.nlm.nih.gov/29043410</a></p></li><li><p>Yonemori, K, et al., &amp; Yamamoto, N (2021). The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study. <i>Japanese journal of clinical oncology</i> 51(5) 693–699. DOI:<a href=&quot;https://doi.org/10.1093/jjco/hyab013&quot;>10.1093/jjco/hyab013</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33621324/&quot;>https://pubmed.ncbi.nlm.nih.gov/33621324</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Niraparib;
